Filing excerpt
Research and development expenses increased $81.5 million, or 37.1%, to $301.1 million for 2025, compared with $219.6 million for 2024.
Source: Autobound Signal API · 101 signals tracked for Insulet · updated
Get Insulet's live signals in Claude or ChatGPT, or by API
What changed at Insulet this week? Use Autobound signals for insulet.com.The company is heavily investing in its product pipeline, including the next-gen Omnipod 6 and integrations with new sensors.
Filing excerpt
Research and development expenses increased $81.5 million, or 37.1%, to $301.1 million for 2025, compared with $219.6 million for 2024.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Vendors
sec-10kautomationInvestmentGet every 10-K signal for Insulet and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Insulet this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/0a056f75-34a8-45e3-971c-f6bfe7711421 returns this record as JSON. POST /v1/companies/enrich returns every signal for insulet.com.
{
"signal_id": "0a056f75-34a8-45e3-971c-f6bfe7711421",
"signal_type": "sec-10k",
"signal_subtype": "automationInvestment",
"detected_at": "2026-02-24T09:29:25.523+00:00",
"company": {
"name": "Insulet",
"domain": "insulet.com"
},
"data": {
"detail": "The company is heavily investing in its product pipeline, including the next-gen Omnipod 6 and integrations with new sensors. This significant budget increase and associated hiring create opportunities for vendors supporting R&D, clinical trials, and product development.",
"metrics": {
"pct": 0.371,
"timeframe": "current_year",
"pct_context": "Increase in R&D expenses",
"dollar_context": "Increase in R&D expenses",
"dollar_millions": 81.5
},
"summary": "R&D spending increased by $81.5M (37.1%) to $301.1M in 2025 for new product development.",
"excerpts": "Research and development expenses increased $81.5 million, or 37.1%, to $301.1 million for 2025, compared with $219.6 million for 2024.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm",
"filing_date": "2026-02-18",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Automation vendor opportunity",
"signal_category": "technology",
"vendors_mentioned": [
"Abbott"
],
"technologies_mentioned": [
"automated insulin delivery"
]
}
}
curl https://signals.autobound.ai/v1/signals/0a056f75-34a8-45e3-971c-f6bfe7711421 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"insulet.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.